StatPearls, LLC

  • Chest Pain
  • Lupus Erythematosus, Systemic
  • Sjogren's Syndrome

Shrinking Lung Syndrome

Shrinking lung syndrome (SLS) is a complication of systemic autoimmune disease, most commonly seen in systemic lupus erythematosus but also reported in Sjogren syndrome, rheumatoid arthritis, and scleroderma. It is characterized by dyspnoea with or without pleuritic chest pain, the elevation of the hemidiaphragm, and restrictive physiology on lung function testing, This rare condition can have serious complications including marked dyspnoea and more rarely, respiratory failure. To avoid the significant morbidity and mortality associated with this condition, it must be promptly diagnosed and treated. This activity reviews the evaluation and treatment of shrinking lung syndrome and highlights the role of the interprofessional team in evaluating and treating patients with this condition.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 credit

MOC types

ABS — Accredited CMEUp to 1 pointABPATH — Lifelong LearningUp to 1 pointABTS — Accredited CMEUp to 1 pointABIM — Medical KnowledgeUp to 1 pointABS — Self-AssessmentUp to 1 pointABP — Lifelong Learning and Self-AssessmentUp to 1 pointABTS — Self-AssessmentUp to 1 point

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 7 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left